Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
Wellgistics Rg (NASDAQ Cons)
Závěr k 13.2.2026 Změna (%) Změna (USD) Objem obchodů (USD)
0,2788 -0,85 0,00 113 465
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiWellgistics Health Inc
TickerWGRX
Kmenové akcie:Ordinary Shares
RICWGRX.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 30.09.2024 31
Akcie v oběhu k 19.11.2025 89 729 281
MěnaUSD
Kontaktní informace
Ulice3000 Bayport Drive Suite 950
MěstoTAMPA
PSČ33607
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon13 026 587 581
Fax13026555049

Business Summary: Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Wellgistics Health Inc revenues increased from $5.7M to $21.7M. Net loss increased from $2.5M to $73.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Home delivery services segment loss increase from $1.7M to $68.4M. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.05 to -$1.19.
Odvětvová klasifikace
TRBC2012Medical Software & Technology Services
MGINDUSTRYSoftware & Programming
MGSECTORTechnology
NAICSSoftware Publishers
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICSPharmaceutical Preparation Manufacturing
NAICSProcess, Physical Distribution, and Logistics Consulting Services
SICPrepackaged Software
SICDrugs/proprietaries/sundries
SICPharmaceutical Preparations
SICManagement Consulting Services



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardSurendra Ajjarapu54
President, Interim Chief Executive Officer, DirectorPrashant Patel5113.10.2025
Interim Chief Financial OfficerEric Sherb3807.10.202507.10.2025
President, Healthcare OperationsNikul Panchal48
Executive Vice President Supply Chain OperationsBrett Bryant42
Executive Vice President Healthcare OperationsShafaat Pirani35
Chief Technology Officer, Vice President - TechnologyBrett Thompson-
Vice President - FinanceScott Madsen42
Director of ComplianceDoug Edmund48